Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty

Table 1

Distribution of major complications

Major complications		Group 1 (46)	Group 2 (123)	Group 3 (45)	Total (214)
Bleeding causing a decrease in the amount of Hb more than 2 g/dl	10	5 (11.1%)	5 (4%)	0	10 (4.6%)
Bleeding causing more than two units of blood transfusion	16	0	10 (8.13%)	6 (13%)	16 (7.4%)
Bleeding causing treatment discontinuation or requiring reoperation for bleeding control	0	0	0	0	0
Symptomatic retroperitoneal, intracranial, intraocular, or intraspinal bleeding	0	0	0	0	0
Fatal bleeding	0	0	0	0	0
Total	26	5 (2.3%)	15 (7%)	6 (2.8%)	26 (23%)